Risk of insufficient funding for business succession at medical institutions
First written in FY2020-Q1. 2 of 3 entries say "Restated". Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022RestatedAnnual report
「Our group provides loans, including working capital loans, to some alliance medical institutions.」
The risks of insufficient funding and loan recovery associated with lending and financial support for alliance medical institutions continue as credit and receivables management risks. - FY2020-Q2RestatedAnnual report
「We pursue business succession at medical institutions in order to form alliances with them. However, if we fail to develop sources of funding for business succession, we may lack sufficient funds to deploy and be unable to secure adequate capacity for business succession.」
The risk of insufficient funding if sources of funding for business succession at medical institutions cannot be developed continues to be stated. - FY2020-Q1First statedAnnual report
「We pursue business succession at medical institutions in order to form alliances with them. However, if we fail to develop sources of funding for business succession, we may lack sufficient funds to deploy and be unable to secure adequate capacity for business succession.」
For the first time, the risk of insufficient funding if the company fails to develop sources of funding required for alliances with medical institutions and business succession was identified.